Dr. Simone Carneiro holds a Pharmacy degree and completed her Ph.D. in Biotechnology at the Federal University of Ouro Preto (UFOP), Brazil, in 2019. During her doctoral studies, she embarked on a year of international mobility at Université Paris-Sud, France, further enriching her research on the development of inhaled nanoparticles for tuberculosis treatment. Currently, she serves as a Postdoc at the Ludwig-Maximilians-University of Munich, Germany. She is funded by the Georg Forster Research Fellowship, a prestigious grant awarded by the Alexander von Humboldt Foundation. Her research is primarily centered on the development of RNA-based lipid nanoparticles for pulmonary delivery. She has experience with formulation characterization, optimization, and in vitro assessment, including several techniques. She continuously contributes with her research field through publications covering nanomedicines, drug delivery, and biointerfaces, and she also involved in patent applications.